2-naphthol has been researched along with Parkinson Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gulwadi, AG; Korpinen, CD; Mailman, RB; Nichols, DE; Sit, SY; Taber, MT | 1 |
1 other study(ies) available for 2-naphthol and Parkinson Disease
Article | Year |
---|---|
Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Chromatography, High Pressure Liquid; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Tolerance; Hydroxydopamines; Isoquinolines; Male; Naphthols; Neostriatum; Parkinson Disease; Quinpirole; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation; Stereotyped Behavior; Sympathectomy, Chemical | 2001 |